Study Details
A Study to Assess the Efficacy and Safety of IMAB362 in Combination with Nab-Paclitaxel and Gemcitabine (Nab-P + GEM) as First Line Treatment in Subjects with Claudin 18.2 (CLDN18.2) Positive, Metastatic Pancreatic Adenocarcinoma
Clinicaltrials.gov ID
Astellas Study ID
8951-CL-5201
EudraCT ID
2018-002551-15
Condition
Pancreatic Cancer
Phase
Phase 2
Age
18 Years - N/A
Sex
Female & Male
Product
zolbetuximab
Type
Interventional
Trial Dates
Mar 2019 - Apr 2025
Masking
None (Open Label)
Enrollment number
369
A Phase 2, Open-Label, Randomized Study to Assess the Efficacy and Safety of Zolbetuximab (IMAB362) in Combination with Nab-Paclitaxel and Gemcitabine (Nab-P + GEM) as First Line Treatment in Subjects with Claudin 18.2 (CLDN18.2) Positive, Metastatic Pancreatic Adenocarcinoma
Study summary
Get More Information
Would you like more information about clinical trial sites that are recruiting participants for A Study to Assess the Efficacy and Safety of IMAB362 in Combination with Nab-Paclitaxel and Gemcitabine (Nab-P + GEM) as First Line Treatment in Subjects with Claudin 18.2 (CLDN18.2) Positive, Metastatic Pancreatic Adenocarcinoma? Contact us by filling our your information to the right and we’ll respond to you.
Locations
Memorial Sloan-Kettering Cancer Center
New York, United States, 10022
Site JP81007
Nagoya, Japan
Site FR33010
Brest, France, 9GV7+4G
Site JP81006
Yokohama, Japan
Site ES34005
Lleida, Spain, 25198
Ochsner Health System
New Orleans, United States, 70121
Site ES34014
Caceres, Spain, 10003
University of Kansas Cancer Center
Westwood, United States, 66205
Cancer Treatment Centers of America, Chicago
Zion, United States, 60099
Site IT39003
Milan, Italy, 20141
Lynn Cancer Institute
Boca Raton, United States, 33486
Site ES34004
Llobregat, Spain, 08908
Site FR33008
Besancon, France, 6XG7+42
Northwell Health Cancer Institute
Lake Success, United States, 11042
Site JP81004
Fukuoka, Japan
Baptist Health
Miami, United States, 33176
Site AU61008
Gosford, Australia, NSW 2250
Mercy Clinic Oklahoma Communities, Inc
Oklahoma City, United States, 73120
Site JP81005
Sapporo, Japan
Site IT39004
Candiolo, Italy, 10060
Site KR82002
Seoul, Republic of Korea, F3QP+76
Site ES34013
Barcelona, Spain, 08036
PMG Research of McFarland Clinic
Ames, United States, 50010
Site FR33004
Saint-Étienne, France, 42000
Site JP81011
Bunkyo-ku, Japan
Site TW88607
Tainan City, Taiwan, Province of China, 73657
Cancer Treatment Centers of Phoenix
Goodyear, United States, 85338
Site FR33003
Aquitaine, France, 33604
Site KR82001
Seoul, Republic of Korea, 03080
Site KR82005
Seongnam-Si, Republic of Korea, 013620
Site KR82003
Seoul, Republic of Korea, 120-752
Site ES34015
Madrid, Spain, 28027
Site KR82006
Seoul, Republic of Korea, G234+36
Site ES34009
Madrid, Spain, 28034
Our Lady of the Lake
Baton Rouge, United States, 70809
Site FR33017
Rouen, France, 76000
Site ES34012
Madrid, Spain, 28046
Scott and White Memorial Hospital
Temple, United States, 76508
Site ES34008
Madrid, Spain, 28050
Site IR35301
Elm Park, Ireland, D04 T6F4
Site AU61007
Wollongong, Australia, HVGM+3C
Site ES34006
Madrid, Spain, 28033
Site FR33009
Nancy, France, 54000
Site KR82007
Seoul, Republic of Korea, 152-703
UCLA Hematology Oncology
Santa Monica, United States, 90404
TOI Clinical research
Whittier, United States, 90603
David C Pratt Cancer Center
Creve Coeur, United States, 63141
Site FR33015
Caen, France, 14076
Houston Methodist Hospital
Houston, United States, 77030
Site IT39002
Cremona, Italy, 26100
Site FR33006
Chambray, France, 37170
Site ES34016
Madrid, Spain, 28027
Site ES34007
Barcelona, Spain, 08916
Site JP81001
Kashiwa, Japan
Site TW88604
Tainan, Taiwan, Province of China, 70457
Site TW88606
Taoyuan, Taiwan, Province of China, 83301
Site KR82004
Seoul, Republic of Korea, 138-736
Site FR33011
Dijon, France, 21079
MultiCare Regional Cancer Center - Gig Harbor
Gig Harbor, United States, 98335
Site FR33014
Plerin, France, 22190
Site JP81010
Osaka, Japan
Site AU61005
Fitzroy, Australia, 5XRF+WX
Site JP81012
Chuo-ku, Japan
Cancer Treatment Centers of America at Eastern Regional Medical Center
Philadelphia, United States, 19124
Site TW88605
Taipei City, Taiwan, Province of China, 2GR9+7H
Roswell Park Cancer Institute
Buffalo, United States, 14203
Site AU61006
Warrnambool, Australia, VIC 3280
Site FR33002
Grenoble, France
Midstate Medical Center
Meriden, United States, 06451
Site ES34011
A Coruna, Spain, 15009
Site FR33007
Strasbourg, France, 67000
Site JP81013
Mitaka, Japan
Site TW88603
Tainan City, Taiwan, Province of China, 26CC+4Q
Site FR33012
Herblain, France, 44805
St. Joseph Heritage Medical Group
Fullerton, United States, 92835
Site FR33005
Pringy Cedex, France, 74374
Site ES34003
Pamplona, Spain, 31008
Site TW88601
Taipei City, Taiwan, Province of China, 4G9C+W3
Site FR33016
La Chaussee Saint Victor, France, 41260
Site ES34002
Girona, Spain, 17007
The University of Chicago
Chicago, United States, 60637
Site FR33013
Villejuif, France, 94805
Site IT39006
Rozzano, Italy, 20089
Site IE35303
Cork, Ireland, T12 DV56
Site TW88602
Taichung City, Taiwan, Province of China, 5M5J+36
Site FR33001
Bayonne Cedex, France, 64109
Site ES34010
Barcelona, Spain, 08028
Cancer Treatment Centers of Atlanta
Newnan, United States, 30265
Site ES34001
Sabadell, Spain, 8208
Site AU61002
North Adelaide, Australia, 5006
Utah Cancer Specialists
Salt Lake City, United States, 84106
Site JP81002
Shinjuku-ku, Japan
Site JP81003
Kashihara, Japan
Site JP81008
Suita, Japan
Site JP81009
Wakayama, Japan
Site JP81014
Koto-ku, Japan
Site JP81015
Ube, Japan
Oncology Consultants PA
Houston, United States, 77024
Site KR82008
Suwon-si, Republic of Korea
Site TR90003
Diyarbakir, Turkey
Site TR90004
Ankara, Turkey
Site TR90006
Ankara, Turkey
Site CN86013
Shanghai, China
Site CN86001
Beijing, China
Site CN86003
Zhejiang, China
Site CN86002
Hubei, China
Site CN86007
Tianjin, China
Site CN86006
Shanghai, China
Site CN86008
Beijing, China
Site TR90002
Istanbul, Turkey
Vista Oncology
Olympia, United States, 98502
Site TR90005
Istanbul, Turkey
Site TR90001
Konya, Turkey
Site IT39008
Veneto, Italy
Site FR33019
Roche-Sur-Yon, France
Site FR33020
Lyon Cedex, France
Site CN86024
Shan Xi, China
Site IT39010
Lombardia, Italy
Site CN86011
Jiangsu, China
Site CN86018
Zhejiang, China
Site KR82010
Daegu, Republic of Korea
Site KR82011
Jeollanam-do, Republic of Korea
Site IT39012
Lazio, Italy
Site CN86020
Guangdong, China
Site IT39014
Toscana, Italy
Site CN86005
Jiangsu, China
Site CN86004
Guangdong, China
Site CN86010
Zhengzhou, China
Site CN86025
Jiangsu, China
Site FR33018
Bordeaux, France
Site KR82009
Gyeonggi-do, Republic of Korea
Site FR33023
Pierre Benite, France
Site CN86012
Harbin, China
Site CN86014
Beijing, China
Virginia Mason
Seattle, United States, 98101
Site MX52003
San Luis Potosi, Mexico
Site CN86017
Shijiazhuang, China
Norton Cancer Institute (NCI)
Louisville, United States, 40202
Site ES34020
Madrid, Spain
Site IT39009
Ancona, Italy
Site CN86019
Shanghai, China
Site TW88608
New Taipei City, Taiwan, Province of China
Site TW88609
Taipei City, Taiwan, Province of China
Site CN86022
Xinjiang, China
Site CN86023
Shandong, China
Site BR55003
Itajai, Brazil
Site BR55004
Santa Catarina, Brazil
Site BR55008
Rio Grande do Sul, Brazil
Site MX52004
Distrito Federal, Mexico
Site MX52005
Veracruz, Mexico
Site CN86009
Chongqing, China
Site CN86016
Guangzhou, China
Site CN86026
Changchun, China
Site FR33021
Nice Cedex 2, France
Site ES34021
Barcelona, Spain
Memorial Sloan Kettering Bergen
Montvale, United States, 07645
Memorial Sloan Kettering Commack
Commack, United States, 11725
Memorial Sloan Kettering Basking Ridge
Basking Ridge, United States, 07920
Memorial Sloan Kettering Westchester
West Harrison, United States, 10604
Memorial Sloan Kettering Nassau
Uniondale, United States, 11553
Memorial Sloan Kettering Monmouth
Middletown, United States, 07748
Holden Comprehensive Cancer Center
Iowa City, United States, 52242
Inova Dwight and Martha Schar
Fairfax, United States, 22031
Site ES34018
Barcelona, Spain
Site BR55001
Sao Paulo, Brazil
Hoag Hospital
Newport Beach, United States, 92663
Site BR55002
Porto Alegre, Brazil
Site BR55006
Sao Paulo, Brazil
Site IT39015
Bologna, Italy
University of Illinois at Chicago
Chicago, United States, 60612
Site ES34017
Santiago de Compostela, Spain
Site ES34026
Malaga, Spain
Site ES34024
Santander, Spain
Site ES34025
Castello de la plana, Spain
The purpose of this website is to offer education and information to patients and their families and friends, the public, and healthcare professionals about the clinical trial process. In addition, the website will provide specific information about Astellas clinical trials. Please read the complete Astellas Transparency Policy to learn about the clinical trial information available on this website
© ASTELLAS PHARMA GLOBAL DEVELOPMENT, INC.
POWERED BY:
